These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2551389)

  • 1. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
    Tal DM; Yanuck MD; van Hall G; Karlish SJ
    Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
    Yasuhara T; Mori M; Wakamatsu K; Kubo K
    Biochem Biophys Res Commun; 1991 Jul; 178(1):95-103. PubMed ID: 1648917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous "ouabain-like" activity in bovine plasma.
    Tal DM; Katchalsky S; Lichtstein D; Karlish SJ
    Biochem Biophys Res Commun; 1986 Feb; 135(1):1-8. PubMed ID: 3006675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of unsaturated fatty acids to Na+, K(+)-ATPase leading to inhibition and inactivation.
    Swarts HG; Schuurmans Stekhoven FM; De Pont JJ
    Biochim Biophys Acta; 1990 May; 1024(1):32-40. PubMed ID: 2159804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 11,13-dihydroxy-14-octadecaenoic acid as a circulating Na+/K(+)-ATPase inhibitor.
    Lichtstein D; Samuelov S; Gati I; Felix AM; Gabriel TF; Deutsch J
    J Endocrinol; 1991 Jan; 128(1):71-8. PubMed ID: 1847965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma.
    Tamura M; Kuwano H; Kinoshita T; Inagami T
    J Biol Chem; 1985 Aug; 260(17):9672-7. PubMed ID: 2991258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
    Tamura M; Harris TM; Higashimori K; Sweetman BJ; Blair IA; Inagami T
    Biochemistry; 1987 May; 26(10):2797-806. PubMed ID: 3038164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Na+,K+-ATPase inhibitors of volume-expanded hog plasma.
    Inagami T; Tamura M
    Hypertension; 1987 Nov; 10(5 Pt 2):I108-12. PubMed ID: 2824359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
    Gonick HC; Weiler EW; Prins BA; Purdy RE
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl sulfoxide inhibits renal Na(+)-K(+)-ATPase at a site different from ouabain and atrial peptides.
    Chiou S; Vesely DL
    Life Sci; 1995; 57(10):945-55. PubMed ID: 7643719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.
    Akagawa K; Hara N; Tsukada Y
    J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
    Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of fatty acid interaction with ouabain and vanadate binding to (Na+ + K+)-activated ATPase.
    Hansen O
    Biochim Biophys Acta; 1989 Nov; 986(1):130-4. PubMed ID: 2554979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Purification of an endogenous inhibitor of sodium-potassium-ATPase].
    Cloix JF; Miller ED; Pernollet MG; Devynck MA; Meyer P
    C R Seances Acad Sci III; 1983 Feb; 296(5):213-6. PubMed ID: 6303528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
    Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of an (Na+ + K+)-ATPase proteolipid labeled with a photoaffinity derivative of ouabain.
    Collins JH; Forbush B; Lane LK; Ling E; Schwartz A; Zot A
    Biochim Biophys Acta; 1982 Mar; 686(1):7-12. PubMed ID: 6279154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.